← Eichor
Study identifier: NCT07233447 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Prevalence of H. Pylori in Stomach Cancers in the West Indies

Condition: Oncology Epidemiology · Risk Factors  ·  Sponsor: Centre Hospitalier Universitaire de la Guadeloupe

PhaseN/A
Planned participants100
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

The incidence and mortality of stomach cancer are higher in the French West Indies than in mainland France. The prevalence of H. pylori infection associated with this cancer remains unknown in these populations. The main objective of the study is to estimate the prevalence of H. Pylori detected by immunohistochemistry in patients newly diagnosed with cancer.

This description comes directly from the study's public registry record.

Talk to the study team

Mélanie petapermal, Master degree  ·  +590590934667  ·  melanie.petapermal@chu-guadeloupe.fr

Valérie Hamony Soter  ·  +590590934677  ·  valerie.soter@chu-guadeloupe.fr

Always discuss trial participation with your own doctor first.

Locations (2)

Cabinet Galeries de HouelbourgBaie-Mahault, GuadeloupeRecruiting
CHU de la GuadeloupePointe-à-Pitre, GuadeloupeRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07233447